Deaf-Blind Disorders: Clinical Trials

2 trials for Deaf-Blind Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Deaf-Blind Disorders: new trials by email Literature Review of Deaf-Blind Disorders trials Research Report on Deaf-Blind Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Tirzepatide - Wolfram Syndrome
Phase 2UnknownOspedale San Raffaele102024-01-012024-02-22
Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome
Depakine - Wolfram Syndrome
Phase 2UnknownCentre d'Etude des Cellules Souches232021-11-262023-11-28

Narrower conditions

Wolfram Syndrome (2)  ·  Diabetes Mellitus (1)

Broader conditions

Abnormalities, Multiple (2)  ·  Blindness (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Cranial Nerve Diseases (2)  ·  Deafness (2)  ·  Diabetes Insipidus (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Ear Diseases (2)  ·  Endocrine System Diseases (2)  ·  Eye Diseases (2)  ·  Eye Diseases, Hereditary (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)

Interventions

Tirzepatide (1)  ·  Valproic Acid (1)

Sponsors

Centre d'Etude des Cellules Souches (1)  ·  Ospedale San Raffaele (1)

Countries

France (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Lorenzo Piemonti, MD (1)